CXCL12 and cancer: Either siRNA silencing or CRISPR-Cas9-based knockout of AHR prevented expression of CYP1A1, but amplified the expression of MMP9, CXCL12 and CXCR4 that contribute to the tumorigenesis and metastasis of the cancer cells.